Cargando…

Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing

Hodgkin lymphoma (HL) is a lymphoproliferative malignancy of B-cell origin that accounts for 10% of all lymphomas. Despite evidence suggesting strong familial clustering of HL, there is no clear understanding of the contribution of genes predisposing to HL. In this study, whole genome sequencing (WG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Aayushi, Giangiobbe, Sara, Kumar, Abhishek, Paramasivam, Nagarajan, Dymerska, Dagmara, Behnisch, Wolfgang, Witzens-Harig, Mathias, Lubinski, Jan, Hemminki, Kari, Försti, Asta, Bandapalli, Obul Reddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Bioengineering and Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067901/ https://www.ncbi.nlm.nih.gov/pubmed/32211398 http://dx.doi.org/10.3389/fbioe.2020.00179

Ejemplares similares

Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer
por: Skopelitou, Diamanto, et al.
Publicado: (2022)

Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer
por: Skopelitou, Diamanto, et al.
Publicado: (2021)

A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer
por: Skopelitou, Diamanto, et al.
Publicado: (2021)

Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer
por: Miao, Beiping, et al.
Publicado: (2022)

Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer
por: Zhu, Lizhen, et al.
Publicado: (2022)

A rare large duplication of MLH1 identified in Lynch syndrome
por: Kumar, Abhishek, et al.
Publicado: (2021)

Cancer Predisposition Genes in Cancer-Free Families
por: Zheng, Guoqiao, et al.
Publicado: (2020)

Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways
por: Srivastava, Aayushi, et al.
Publicado: (2019)

Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2021)

A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2020)

Pedigree based DNA sequencing pipeline for germline genomes of cancer families
por: Försti, Asta, et al.
Publicado: (2016)

Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family
por: Kumar, Abhishek, et al.
Publicado: (2018)

Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
por: Hemminki, Kari, et al.
Publicado: (2020)

Characterization of rare germline variants in familial multiple myeloma
por: Catalano, Calogerina, et al.
Publicado: (2021)

Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer
por: Slater, Emily P., et al.
Publicado: (2021)

Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2018)

Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Evidence of Inbreeding in Hodgkin Lymphoma
por: Thomsen, Hauke, et al.
Publicado: (2016)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
por: Hemminki, Kari, et al.
Publicado: (2022)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century
por: Koskinen, Anni, et al.
Publicado: (2022)

Survival trends in hematological malignancies in the Nordic countries through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment
por: Hemminki, Kari, et al.
Publicado: (2023)

Conditional survival in breast cancer up to 10 years in the Nordic countries
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma
por: Niazi, Yasmeen, et al.
Publicado: (2022)

Efficient Synergistic Single-Cell Genome Assembly
por: Movahedi, Narjes S., et al.
Publicado: (2016)

Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development
por: Lascorz, Jesús, et al.
Publicado: (2011)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
por: Hemminki, Kari, et al.
Publicado: (2021)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
por: Hemminki, Kari, et al.
Publicado: (2021)

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
por: Hemminki, Kari, et al.
Publicado: (2023)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
por: Tichanek, Filip, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jt0v9j7thqr3sev686o4dinkik